Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1.

Roake, J A; Rao, A S; Morris, P J; Larsen, C P; Hankins, D F; Austyn, J M

Roake, J A; Rao, A S; Morris, P J; Larsen, C P; Hankins, D F; Austyn, J M.

Affiliation

Roake JA; Nuffield Department of Surgery, University of Oxford, John Radcliffe Hospital, Headington, United Kingdom.

J Exp Med ; 181(6): 2237-47, 1995 Jun 01.

Article in En | MEDLINE | ID: mdl-7760009

Subject(s)

Dendritic Cells/drug effects; Interleukin-1/pharmacology; Lipopolysaccharides/pharmacology; Skin/immunology; Tumor Necrosis Factor-alpha/pharmacology; Animals; Antibodies, Monoclonal; Antigens, Differentiation/analysis; Cells, Cultured; Dendritic Cells/pathology; Dose-Response Relationship, Drug; Heart/drug effects; Humans; Immunohistochemistry; Interleukin-2/pharmacology; Kidney/drug effects; Kidney/immunology; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Myocardium/immunology; Organ Specificity; Recombinant Proteins/pharmacology; Skin/drug effects

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin / Dendritic Cells / Lipopolysaccharides / Interleukin-1 / Tumor Necrosis Factor-alpha Limits: Animals / Humans / Male Language: En Journal: J Exp Med Year: 1995 Type: Article Affiliation country: United kingdom

Fulltext

XML

PubMed Links

Search on Google